the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

AmBank sees ringgit rising to RM4.50 against US dollar by year-end

KUALA LUMPUR: AmBank Economic Research is forecasting the ringgit to appreciate further to around RM4.50 against the US dollar by the year-end due to a combination of factors, including the potential narrowing interest rate differentials between the currencies which is more beneficial to the local unit.

“Nevertheless, actual USD/MYR has moved below these levels (last week at 4.685). Again, we repeat that our model already suggests that the current fair value of USD/MYR is about 4.50/60,” it said in a research note today.

It also emphasised that Malaysia’s economic fundamentals remain solid.

Aiding the sentiment for the local unit and continuing the advantageous repositioning of the currency in the short term is Bank Negara Malaysia’s (BNM) stable and consistent monetary policy direction which pacifies the market.

Additionally, the US Federal Reserve (Fed) is anticipated to cut the Federal Fund Rate by the second or third quarter of this year.

No less important were coordinated efforts by the central bank to boost inflows from abroad.

The research house highlighted that the weakening of the US Dollar Index and the undervaluation of the ringgit have spurred forex conversions into the local currency, as evidenced by the reversal in forex foreign currency deposits compared to total deposits.

AmBank Group pointed out that BNM has maintained the Overnight Policy Rate (OPR) at 3%, and anticipates that the central bank will maintain OPR at the current level throughout this year despite the ongoing supply-side interventions.

“Malaysia’s economic fundamentals remain solid and far from a recession, unlike in advanced economies; the expected smaller interest rate differentials and the Fed’s clear signal of an impending rate cut are positive on the ringgit.

“We maintain our end-year forecast of 4.50 with a possible downside of 4.60 per dollar,” it added. – Bernama

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings